Furthermore, while IL-36 signaling—strongly induced by TNF-α and IL-17—has been established as a driver of plaque psoriasis, its inhibition has been shown to reduce inflammation and Th17 cell activity, potentially contributing to the unique pustule formation observed in PPP [31,32,33,34]. Here, TNF is linked to psoriasis vulgaris.